Macular edema after rhegmatogenous retinal detachment repair: risk factors, OCT analysis, and treatment responses.

Corticosteroids Intravitreal injection Macular edema Retinal detachment Spectral-domain optical coherence tomography Vitrectomy

Journal

International journal of retina and vitreous
ISSN: 2056-9920
Titre abrégé: Int J Retina Vitreous
Pays: England
ID NLM: 101677897

Informations de publication

Date de publication:
25 Jan 2021
Historique:
received: 28 05 2020
accepted: 28 10 2020
entrez: 26 1 2021
pubmed: 27 1 2021
medline: 27 1 2021
Statut: epublish

Résumé

To investigate risk factors, imaging characteristics, and treatment responses of cystoid macular edema (CME) after rhegmatogenous retinal detachment (RRD) repair. Consecutive, retrospective case-control series of patients who underwent pars plana vitrectomy (PPV) and/or scleral buckling (SB) for RRD, with at least six months of follow-up. Clinical and surgical parameters of patients with and without CME (nCME), based on spectral-domain optical coherence tomography (OCT), were compared. Of 99 eyes enrolled, 25 had CME while 74 had nCME. Patients with CME underwent greater numbers of surgeries (P < 0.0001). After adjusting for number of surgeries, macula-off RRD (P = 0.06), proliferative vitreoretinopathy (PVR) (P = 0.09), surgical approach (PPV and/or SB, P = 0.21), and tamponade type (P = 0.10) were not statistically significant, although they all achieved significance on univariate analysis (P = 0.001 or less). Intraoperative retinectomy (P = 0.009) and postoperative pseudophakia or aphakia (P = 0.008) were more frequent in the CME group, even after adjustment. Characteristics of cCME on OCT included diffuse distribution, confluent cysts, and absence of subretinal fluid or intraretinal hyperreflective foci. Macular thickness improved significantly with intravitreal triamcinolone (P = 0.016), but not with anti-vascular endothelial growth factor agents (P = 0.828) or dexamethasone implant (P = 0.125). After adjusting for number of surgeries and macular detachment, final visual acuities remained significantly lower in the CME vs nCME group (P = 0.012). Risk factors of CME include complex retinal detachment repairs requiring multiple surgeries, and pseudophakic or aphakic lens status. Although this cCME was associated with poor therapeutic response, corticosteroids were the most effective studied treatments.

Identifiants

pubmed: 33494835
doi: 10.1186/s40942-020-00254-9
pii: 10.1186/s40942-020-00254-9
pmc: PMC7831177
doi:

Types de publication

Journal Article

Langues

eng

Pagination

9

Subventions

Organisme : UCLA Health System
ID : CTSI Grant Number UL1TR001881

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Am J Ophthalmol. 2006 Sep;142(3):405-12
pubmed: 16935584
Retina. 2016 Jul;36(7):1244-51
pubmed: 26655611
Retina. 2014 Nov;34(11):2218-32
pubmed: 25011028
Graefes Arch Clin Exp Ophthalmol. 2013 May;251(5):1373-82
pubmed: 23250478
Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4003-4014
pubmed: 28800647
Ophthalmology. 1980 Nov;87(11):1090-5
pubmed: 7243204
Retina. 2009 Mar;29(3):387-94
pubmed: 19092729
Surv Ophthalmol. 2015 Mar-Apr;60(2):123-37
pubmed: 25438734
Arch Ophthalmol. 1999 Jun;117(6):744-51
pubmed: 10369584
Dev Ophthalmol. 2010;47:10-26
pubmed: 20703041
Graefes Arch Clin Exp Ophthalmol. 1986;224(1):13-7
pubmed: 3943728
Am J Ophthalmol. 1983 Apr;95(4):451-6
pubmed: 6340512
Ophthalmology. 2017 Jun;124(6):757-767
pubmed: 28237428
Expert Opin Drug Metab Toxicol. 2017 Dec;13(12):1217-1224
pubmed: 29134820
Retina. 2018 Jun;38(6):1084-1090
pubmed: 28622270
J Fr Ophtalmol. 1993;16(4):259-63
pubmed: 8326107
Am J Ophthalmol. 2005 Aug;140(2):200-6
pubmed: 15992752
Arch Ophthalmol. 1980 Jul;98(7):1230-2
pubmed: 7396774
Retina. 2009 Feb;29(2):232-42
pubmed: 18997641
Mediators Inflamm. 2013;2013:971758
pubmed: 24288446
Korean J Ophthalmol. 2018 Jun;32(3):204-210
pubmed: 29022299
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1236-40
pubmed: 16505064
Retina. 2012 Jan;32(1):43-53
pubmed: 21778929
Prog Retin Eye Res. 2018 Mar;63:20-68
pubmed: 29126927
Retina. 2016 Oct;36(10):1823-42
pubmed: 27328171
Eye (Lond). 2007 Jun;21(6):831-4
pubmed: 16710429
Ophthalmology. 1998 Mar;105(3):397-405
pubmed: 9499767
Prog Retin Eye Res. 2016 Mar;51:125-55
pubmed: 26209346
Eye (Lond). 2017 Apr;31(4):566-571
pubmed: 27935601
Am J Ophthalmol. 2007 Dec;144(6):872-877
pubmed: 17937924
Am J Ophthalmol. 2008 Jun;145(6):1071-1076
pubmed: 18374302
Retina. 2005 Jul-Aug;25(5):556-60
pubmed: 16077349

Auteurs

Cameron Pole (C)

Retina Division, Stein Eye Institute, University of California Los Angeles, 100 Stein Plaza, Los Angeles, CA, 90095-7002, USA.

Ismael Chehaibou (I)

Retina Division, Stein Eye Institute, University of California Los Angeles, 100 Stein Plaza, Los Angeles, CA, 90095-7002, USA.
Ophthalmology Department, AP-HP, Hôpital Lariboisière, Université de Paris, 75010, Paris, France.

Andrea Govetto (A)

Ophthalmology Department, Fatebenefratelli-Oftalmico Hospital, ASST-Fatebenefratelli-Sacco, Milan, Italy.

Sean Garrity (S)

Tufts Medical Center/New England Eye Center, Ophthalmic Consultants of Boston, Boston, MA, USA.

Steven D Schwartz (SD)

Retina Division, Stein Eye Institute, University of California Los Angeles, 100 Stein Plaza, Los Angeles, CA, 90095-7002, USA.

Jean-Pierre Hubschman (JP)

Retina Division, Stein Eye Institute, University of California Los Angeles, 100 Stein Plaza, Los Angeles, CA, 90095-7002, USA. hubschman@jsei.ucla.edu.

Classifications MeSH